Training Series

Virtual meeting

Via Zoom

Description

This training will review how to recognize overamping events likely to benefit from medication intervention. We will describe how to use benzodiazepines and antipsychotics to manage psychotic symptoms associated with overamping. Additionally, we will provide a brief overview of medications that may be appropriate to manage hypertensive crisis in the setting of overamping to prevent worse cardiac outcomes.

Intended audience

Providers, nurses, peer supports, other clinical staff, and non-clinicians.

Speakers

Meg is a clinical nurse educator with Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance and a psychiatric mental health nurse practitioner at Boston Medical Center. Prior to obtaining her MSN, she worked as a nurse care manager in the Stimulant Treatment and Recovery Clinic (START) clinic, integrating harm reduction, infectious disease treatment, medical addiction groups, and co-management of stimulant use disorders and mental health conditions. Her clinical expertise includes harm reduction, low barrier treatment, complex care management, early identification and management of acute and persistent stimulant-induced psychosis. She earned both her BSN and MSN from Regis College.

Dawn is an Advanced Practice Nurse specializing in Addictions Consultation within the Emergency Department at Massachusetts General Hospital. She addresses the treatment needs of individuals and families impacted by addiction and mental health issues in emergency settings. Dawn also provides training and supervision for clinical staff, develops and implements policies related to patient care, and assists in establishing patient treatment plans. Dr. Williamson earned her BSN from the University of Massachusetts and her Master of Science in Adult Mental Health Nursing from Northeastern University. She holds Board Certification as a Clinical Specialist in Adult Psychiatric and Mental Health Nursing and is a Certified Advanced Practice Addictions Registered Nurse. With twenty-eight years of nursing experience, she has worked in the public and private sectors before joining Massachusetts General Hospital.

Objectives

Following this training, participants will have the knowledge to:

1. Recognize episodes of overamping that would benefit from a medication intervention.
2. Name two classes of medications effective in treating acute psychotic symptoms of overamping.
3. Identify medications effective at addressing the hypertensive crisis associated with overamping.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training.
2. Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME and Nursing

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 0.50 contact hours, of which 0.50 are eligible for pharmacology credit.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits. 

Community Health Worker

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Board of Community Health Workers to award community health workers who complete this training 0.50 continuing education credits.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Hide details

Virtual meeting

Via Zoom

Description

This training will review how to recognize overamping events likely to benefit from medication intervention. We will describe how to use benzodiazepines and antipsychotics to manage psychotic symptoms associated with overamping. Additionally, we will provide a brief overview of medications that may be appropriate to manage hypertensive crisis in the setting of overamping to prevent worse cardiac outcomes.

Intended audience

Providers, nurses, peer supports, other clinical staff, and non-clinicians.

Speakers

Meg is a clinical nurse educator with Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance and a psychiatric mental health nurse practitioner at Boston Medical Center. Prior to obtaining her MSN, she worked as a nurse care manager in the Stimulant Treatment and Recovery Clinic (START) clinic, integrating harm reduction, infectious disease treatment, medical addiction groups, and co-management of stimulant use disorders and mental health conditions. Her clinical expertise includes harm reduction, low barrier treatment, complex care management, early identification and management of acute and persistent stimulant-induced psychosis. She earned both her BSN and MSN from Regis College.

Dawn is an Advanced Practice Nurse specializing in Addictions Consultation within the Emergency Department at Massachusetts General Hospital. She addresses the treatment needs of individuals and families impacted by addiction and mental health issues in emergency settings. Dawn also provides training and supervision for clinical staff, develops and implements policies related to patient care, and assists in establishing patient treatment plans. Dr. Williamson earned her BSN from the University of Massachusetts and her Master of Science in Adult Mental Health Nursing from Northeastern University. She holds Board Certification as a Clinical Specialist in Adult Psychiatric and Mental Health Nursing and is a Certified Advanced Practice Addictions Registered Nurse. With twenty-eight years of nursing experience, she has worked in the public and private sectors before joining Massachusetts General Hospital.

Objectives

Following this training, participants will have the knowledge to:

1. Recognize episodes of overamping that would benefit from a medication intervention.
2. Name two classes of medications effective in treating acute psychotic symptoms of overamping.
3. Identify medications effective at addressing the hypertensive crisis associated with overamping.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training.
2. Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME and Nursing

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 0.50 contact hours, of which 0.50 are eligible for pharmacology credit.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits. 

Community Health Worker

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Board of Community Health Workers to award community health workers who complete this training 0.50 continuing education credits.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Hide details

Virtual meeting

Via Zoom

Description

This training will review the available evidence for the use of medications to treat stimulant use disorders in patients who can become pregnant. The session will emphasize the importance of shared-decision making with pregnant patients to optimize outcomes related to stimulant use disorders and medication interventions.

Intended audience

Providers, nurses, peer supports, other clinical staff, and non-clinicians.

Speakers

Dr. Smid is board-certified by the American Board of Obstetrics & Gynecology in General Obstetrics & Gynecology and Maternal-Fetal Medicine and by the American Board of Preventive Medicine in Addiction Medicine. She has been an active Utah Perinatal Mortality Committee member since 2016. In addition to her clinical practice, Dr. Smid is an Assistant Professor in the Obstetrics & Gynecology (Primary) and Psychiatry (Adjunct) departments at the University of Utah. She is a member of the Adult Psychiatry and Maternal Fetal Medicine academic divisions, contributing significantly to education and patient care. 

Marcela Smid, MD, MS, MA, receives grant/research support from Gilead and Koko Medical. Faculty member does plan on discussing unlabeled/investigational uses of a commercial product.

Objectives

Following this training, participants will have the knowledge to: 

1. Identify medications used to treat cocaine use disorder in pregnant patients.

2. Identify medications used to treat methamphetamine use disorder in pregnant patients.

3. Discuss the importance of collaborative decision-making in working with pregnant patients with stimulant use disorders interested in medication interventions.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training.
2. Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME and Nursing

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 0.50 contact hours, of which 0.50 are eligible for pharmacology credit.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits. 

Community Health Worker

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Board of Community Health Workers to award community health workers who complete this training 0.50 continuing education credits.

FACULTY & PLANNER DISICLOSURES

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Hide details

Virtual meeting

Via Zoom

Description

This training will review strategies for evaluating available evidence for using medications in the treatment of methamphetamine use disorder. The session will also describe two prescribing strategies for patients with a methamphetamine use disorder and for which patient profiles they may be the most effective. 

Intended audience

Providers, nurses, peer supports, other clinical staff, and non-clinicians.

Speakers

Steven is the Vice Chair for Research in the Department of Family Medicine and a Professor in Family Medicine as well as in Psychiatry and Biobehavioral Sciences. He directs three centers at UCLA: the Center for Behavioral and Addiction Medicine (CBAM), the NIMH-funded P30 AIDS Research Center, and the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He also co-directs the Big South/West Node of NIDA’s Clinical Trials Network. Dr. Shoptaw utilizes these platforms to lead research, clinical, and policy efforts aimed at delivering novel and high-impact strategies to provide culturally competent care and prevention for individuals affected by addictions and HIV. He offers mentorship to clinical and research scholars from diverse backgrounds in the U.S., Vietnam, South Africa, Australia, and Cameroon.

**Steven Shoptaw, PhD, receives grant/research support from Gilead, Alkermes, and Clear Scientific; Faculty member does plan on discussing unlabeled/ investigational uses of a commercial product. 

Objectives

Following this training, participants will have the knowledge to:

1. Name at least two medications with evidence for the treatment of methamphetamine use disorder.

2. Recognize patient profiles most likely to benefit from specific medication interventions for methamphetamine use disorders.

3. Evaluate studies and evidence for medications that treat methamphetamine use disorders.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training.
2. Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME and Nursing

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 0.50 contact hours, of which 0.50 are eligible for pharmacology credit.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits. 

Community Health Worker

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Board of Community Health Workers to award community health workers who complete this training 0.50 continuing education credits.

FACULTY & PLANNER DISICLOSURES

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Hide details

Virtual meeting

Via Zoom

Description

This training will review strategies for evaluating available evidence for using medications in the treatment of methamphetamine use disorder. The session will also describe two prescribing strategies for patients with a methamphetamine use disorder and for which patient profiles they may be the most effective. 

Intended audience

Providers, nurses, peer supports, other clinical staff, and non-clinicians.

Speakers

Steven is the Vice Chair for Research in the Department of Family Medicine and a Professor in Family Medicine as well as in Psychiatry and Biobehavioral Sciences. He directs three centers at UCLA: the Center for Behavioral and Addiction Medicine (CBAM), the NIMH-funded P30 AIDS Research Center, and the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He also co-directs the Big South/West Node of NIDA’s Clinical Trials Network. Dr. Shoptaw utilizes these platforms to lead research, clinical, and policy efforts aimed at delivering novel and high-impact strategies to provide culturally competent care and prevention for individuals affected by addictions and HIV. He offers mentorship to clinical and research scholars from diverse backgrounds in the U.S., Vietnam, South Africa, Australia, and Cameroon.

**Steven Shoptaw, PhD, receives grant/research support from Gilead, Alkermes, and Clear Scientific; Faculty member does plan on discussing unlabeled/ investigational uses of a commercial product. 

Objectives

Following this training, participants will have the knowledge to:

1. Name at least two medications with evidence for the treatment of methamphetamine use disorder.

2. Recognize patient profiles most likely to benefit from specific medication interventions for methamphetamine use disorders.

3. Evaluate studies and evidence for medications that treat methamphetamine use disorders.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training.
2. Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME and Nursing

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 0.50 contact hours, of which 0.50 are eligible for pharmacology credit.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits. 

Community Health Worker

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Board of Community Health Workers to award community health workers who complete this training 0.50 continuing education credits.

FACULTY & PLANNER DISICLOSURES

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Hide details

Virtual meeting

Via Zoom

Description

This training will review the available evidence for the use of medications to treat stimulant use disorders in patients who can become pregnant. The session will emphasize the importance of shared-decision making with pregnant patients to optimize outcomes related to stimulant use disorders and medication interventions.

Intended audience

Providers, nurses, peer supports, other clinical staff, and non-clinicians.

Speakers

Dr. Smid is board-certified by the American Board of Obstetrics & Gynecology in General Obstetrics & Gynecology and Maternal-Fetal Medicine and by the American Board of Preventive Medicine in Addiction Medicine. She has been an active Utah Perinatal Mortality Committee member since 2016. In addition to her clinical practice, Dr. Smid is an Assistant Professor in the Obstetrics & Gynecology (Primary) and Psychiatry (Adjunct) departments at the University of Utah. She is a member of the Adult Psychiatry and Maternal Fetal Medicine academic divisions, contributing significantly to education and patient care.

**Marcela Smid, MD, MS, MA, receives grant/research support from Gilead and Koko Medical; Faculty member does plan on discussing unlabeled/ investigational uses of a commercial product. 

Objectives

Following this training, participants will have the knowledge to: 

1. Identify medications used to treat cocaine use disorder in pregnant patients.

2. Identify medications used to treat methamphetamine use disorder in pregnant patients.

3. Discuss the importance of collaborative decision-making in working with pregnant patients with stimulant use disorders interested in medication interventions.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training.
2. Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME and Nursing

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 0.50 contact hours, of which 0.50 are eligible for pharmacology credit.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits. 

Community Health Worker

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Board of Community Health Workers to award community health workers who complete this training 0.50 continuing education credits.

education credits.

FACULTY & PLANNER DISICLOSURES

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Hide details

Virtual meeting

Via Zoom

Description

This training will review the evidence for using FDA-approved medications for the treatment of opioid and alcohol use disorders in people who also use stimulants. The session will discuss the importance of addressing co-occurring use disorders for patients with significant polysubstance use.

Intended audience

Providers, nurses, peer supports, other clinical staff, and non-clinicians.

Speakers

Objectives

Following this training, participants will have the knowledge to:

1. Name 3 FDA approved medications that may be used to treat co-occurring alcohol use disorder for people with stimulant use disorder (StUD).
2. Name 3 FDA approved medications that may be used to treat co-occurring opioid use disorder for people with StUD.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training.
2. Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME and Nursing

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 0.50 contact hours, of which 0.50 are eligible for pharmacology credit.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits. 

Community Health Worker

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Board of Community Health Workers to award community health workers who complete this training 0.50 continuing education credits.

FACULTY & PLANNER DISICLOSURES

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Hide details